We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Miami Cancer Institute Slated for 2016

By HospiMedica International staff writers
Posted on 07 Apr 2014
A new cancer institute planned for Miami (FL, USA) will consolidate under one roof outpatient clinical services, a dedicated cancer research facility, and signature technology platforms, including the first proton therapy center in South Florida.

The planned Miami Cancer Institute will be located at Baptist Health South Florida (Miami, FL, USA), and will include a 23,000 m2 clinical cancer center, a 11,150 m2 research facility, a brand-new inpatient floor designed especially for cancer patients, and medical offices for cancer specialists. More...
There also will be two parking garages with 1,400 spaces for the convenience of patients and their families. The four-story facility was designed by ZGF Architects (Portland, OR, USA), which also designed the Dana-Farber Cancer Institute and Memorial Sloan-Kettering Cancer Center.

The Miami Cancer Institute plans to offer comprehensive clinical services, such as bone marrow transplant, diagnostic imaging, infusion chemotherapy and radiation therapies, tomotherapy, gamma knife stereotactic radiosurgery, and proton therapy, an advanced treatment that beams radiation directly to the tumor to destroy cancer cells while avoiding healthy tissues. The therapy will also be available to patients throughout Latin America and the Caribbean. The Institute will also promote a robotic surgery program, with special emphasis on gynecology-oncology and thoracic surgery.

“The Miami Cancer Institute at Baptist Health South Florida will be recognized as a world-class destination for providing evidence-based, individualized care for our patients,” said Brian E. Keeley, president and CEO of Baptist Health South Florida. “It will be a state-of-the-art facility that will be unmatched in our region in terms of clinical excellence and advanced cancer care, and we are recruiting nationally renowned experts to lead the Institute.”

“We are combining innovative, precision cancer care and the latest in clinical research with Baptist Health’s well-known high level of patient care – all in one place,” said cancer specialist Leonard Kalman, MD. “This is the most exciting project related to cancer care that I have been involved with in my more than 30 years of practicing oncology in Miami.”

Construction of the Miami Cancer Institute at Baptist Health South Florida is scheduled to start in July 2014.

Related Links:

Baptist Health South Florida
ZGF Architects



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.